Cover Image

Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure

<b>Background:</b> Clozapine is a key antipsychotic drug for treatment-resistant schizophrenia but exhibits highly variable pharmacokinetics and a propensity for serious adverse effects. Currently, these challenges are addressed using therapeutic drug monitoring (TDM). This study primari...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kenneth H. Wills (Author), Stephen J. Behan (Author), Michael J. Nance (Author), Jessica L. Dawson (Author), Thomas M. Polasek (Author), Ashley M. Hopkins (Author), Madelé van Dyk (Author), Andrew Rowland (Author)
Format:	Book
Published:	MDPI AG, 2021-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate
by: Madelé van Dyk, et al.
Published: (2019)

The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling
by: Ghoneim AM, et al.
Published: (2020)

A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution
by: Radwan Ansaar, et al.
Published: (2023)

Delineating gene-environment effects using virtual twins of patients treated with clozapine
by: Sam Mostafa, et al.
Published: (2023)

Alert prescribing of clozapine: a comparison of five drug-drug interaction sources
by: Jeroen Govaerts, et al.
Published: (2024)

Deconvoluting the Complexity of Reactive Oxygen Species (ROS) in Neurodegenerative Diseases
by: Yuxin Zhou, et al.
Published: (2022)

Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia
by: Sam Mostafa, et al.
Published: (2024)

Population pharmacokinetic model and limited sampling strategy for clozapine using plasma and dried blood spot samples
by: Lisanne M. Geers, et al.
Published: (2022)

Deconvolution of the particle size distribution of ProRoot MTA and MTA Angelus
by: William Nguyen Ha, et al.
Published: (2016)

Deconvolution of synthetic mRNA expression: Nucleoside chemistry alters translatability
by: Hanieh Moradian, et al.
Published: (2024)

A tutorial on physiologically based pharmacokinetic approaches in lactation research
by: Amita Pansari, et al.
Published: (2024)

Clozapine clinical toolkit optimizes inpatient clozapine monitoring
by: Brooke Gessner, PharmD, ACPR, et al.
Published: (2024)

HArmonized single-cell RNA-seq Cell type Assisted Deconvolution (HASCAD)
by: Yen-Jung Chiu, et al.
Published: (2023)

Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice
by: Shufang Liu, et al.
Published: (2023)

Narrowing the Gap Between In Vitro and In Vivo Genetic Profiles by Deconvoluting Toxicogenomic Data In Silico
by: Yuan Liu, et al.
Published: (2020)

Deconvoluting human Brodmann area 8 based on its unique structural and functional connectivity
by: Nicholas B. Dadario, et al.
Published: (2023)

Addressing drug safety of maternal therapy during breastfeeding using physiologically‐based pharmacokinetic modeling
by: Xian Pan, et al.
Published: (2022)

Clozapine Induced Pityriasiform Eruption
by: Bhatia M S, et al.
Published: (1997)

Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population
by: Patricia D. Maglalang, et al.
Published: (2024)

Deconvolution at the single-cell level reveals ovarian cell-type-specific transcriptomic changes in PCOS
by: Shumin Li, et al.
Published: (2024)

Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy
by: Jing Ye, et al.
Published: (2023)

Physiologically‐Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan
by: Lei Sun, et al.
Published: (2020)

Using physiologically‐based pharmacokinetic modeling for predicting the effects of hepatic impairment on the pharmacokinetics of olanzapine and samidorphan given as a combination tablet
by: Lei Sun, et al.
Published: (2021)

Characterization of disease-specific cellular abundance profiles of chronic inflammatory skin conditions from deconvolution of biopsy samples
by: Zandra C. Félix Garza, et al.
Published: (2019)

Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations
by: Trevor N. Johnson, et al.
Published: (2022)

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
by: Claas-Frederik Johannsen, et al.
Published: (2022)

Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
by: Victoria Rodriguez, et al.
Published: (2020)

Diltiazem for clozapine-induced generalized hyperhidrosis
by: Kenton Emma M. PharmD, et al.
Published: (2023)

Improved cell composition deconvolution method of bulk gene expression profiles to quantify subsets of immune cells
by: Yen-Jung Chiu, et al.
Published: (2019)

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
by: Venkata K. Yellepeddi, et al.
Published: (2021)

Circulating EVs long RNA-based subtyping and deconvolution enable prediction of immunogenic signatures and clinical outcome for PDAC
by: Yuchen Li, et al.
Published: (2021)

Extensive Direct Subcortical Cerebellum-Basal Ganglia Connections in Human Brain as Revealed by Constrained Spherical Deconvolution Tractography
by: Demetrio eMilardi, et al.
Published: (2016)

A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development
by: Trevor N. Johnson, et al.
Published: (2021)

Evaluation of the drug-drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach
by: Michael J. Hanley, et al.
Published: (2024)

Tubulin/microtubules as novel clozapine targets
by: Mizuki Hino, et al.
Published: (2022)

Clozapine discontinuation withdrawal symptoms in schizophrenia
by: Graham Blackman, et al.
Published: (2021)

Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021)

A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition
by: Chie Emoto, et al.
Published: (2019)

First case series of clozapine induced hypogammaglobulinaemia in England
by: S Elkhalifa, et al.
Published: (2021)

Clozapine Patients at the Interface between Primary and Secondary Care
by: Marita Barrett, et al.
Published: (2018)